Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
FUSED HETEROCYCLIC COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/083201
Kind Code:
A1
Abstract:
The present invention belongs to the technical field of chemical medicines. Disclosed are a fused heterocyclic compound and the use thereof. The fused heterocyclic compound as represented by formula (II) provided in the present invention can be used as a PARP1 inhibitor, has the advantages of high activity and high selectivity, and also has excellent pharmacokinetic properties and excellent safety.

Inventors:
WANG TAIJIN (CN)
JIA TAO (CN)
BAI ZHONGYOU (CN)
LI GANG (CN)
CHEN LIJUAN (CN)
Application Number:
PCT/CN2023/125496
Publication Date:
April 25, 2024
Filing Date:
October 19, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CHENGDU ZENITAR BIOMEDICAL TECH CO LTD (CN)
International Classes:
C07D471/04; A61K31/444; A61P35/00; A61P35/02; A61P35/04; C07D401/14; C07D403/14
Domestic Patent References:
WO2022228387A12022-11-03
WO2023046034A12023-03-30
WO2023051812A12023-04-06
WO2023109521A12023-06-22
WO2009053373A12009-04-30
Foreign References:
CN115232154A2022-10-25
CN116891456A2023-10-17
CN114144413A2022-03-04
CN102341394A2012-02-01
Attorney, Agent or Firm:
CHENGDU HONGQIAO PATENT LAW OFFICE (CN)
Download PDF: